-
1
-
-
0017364058
-
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: A study of 57 autopsy-proven cases
-
Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: A study of 57 autopsy-proven cases. Cancer 1977;39:232-46.
-
(1977)
Cancer
, vol.39
, pp. 232-246
-
-
Okuda, K.1
Kubo, Y.2
Okazaki, N.3
Arishima, T.4
Hashimoto, M.5
-
2
-
-
0023200714
-
Primary liver cancer in Japan: Sixth report
-
Liver cancer study group of Japan
-
Liver cancer study group of Japan. Primary liver cancer in Japan: Sixth report. Cancer 1987;60:1400-11.
-
(1987)
Cancer
, vol.60
, pp. 1400-1411
-
-
-
3
-
-
0032907615
-
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer
-
Raderer M, Hejna MH, Valencak JB, Kornek GV, Weinlander GS, Bareck E, et al. Two consecutive phase II studies of 5-fluorouracil/leucovorin/ mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 1999;56:177-80.
-
(1999)
Oncology
, vol.56
, pp. 177-180
-
-
Raderer, M.1
Hejna, M.H.2
Valencak, J.B.3
Kornek, G.V.4
Weinlander, G.S.5
Bareck, E.6
-
4
-
-
0031871963
-
Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin
-
Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F, et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 1998;9:653-6.
-
(1998)
Ann Oncol
, vol.9
, pp. 653-656
-
-
Ducreux, M.1
Rougier, P.2
Fandi, A.3
Clavero-Fabri, M.C.4
Villing, A.L.5
Fassone, F.6
-
5
-
-
0031817576
-
Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas
-
Chen JS, Jan YY, Lin YC, Wang HM, Chang WC, Liau CT. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas. Anticancer Drugs 1998;9:393-7.
-
(1998)
Anticancer Drugs
, vol.9
, pp. 393-397
-
-
Chen, J.S.1
Jan, Y.Y.2
Lin, Y.C.3
Wang, H.M.4
Chang, W.C.5
Liau, C.T.6
-
6
-
-
0033673668
-
Biliary tract cancer: Our experience with gemcitabine treatment
-
Verderame F, Mandina F, Abruzzo F, Scarpulla M, Di Leo R. Biliary tract cancer: Our experience with gemcitabine treatment. Anticancer Drugs 2000;11:707-8.
-
(2000)
Anticancer Drugs
, vol.11
, pp. 707-708
-
-
Verderame, F.1
Mandina, F.2
Abruzzo, F.3
Scarpulla, M.4
Di Leo, R.5
-
7
-
-
0035108122
-
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
-
Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, et al. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 2001;12:183-6.
-
(2001)
Ann Oncol
, vol.12
, pp. 183-186
-
-
Penz, M.1
Kornek, G.V.2
Raderer, M.3
Ulrich-Pur, H.4
Fiebiger, W.5
Lenauer, A.6
-
8
-
-
0034943861
-
Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas
-
Kubicka S, Rudolph KL, Tietze MK, Lorenz M, Manns M. Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 2001;48:783-9.
-
(2001)
Hepatogastroenterology
, vol.48
, pp. 783-789
-
-
Kubicka, S.1
Rudolph, K.L.2
Tietze, M.K.3
Lorenz, M.4
Manns, M.5
-
9
-
-
0023238952
-
Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells
-
Fram RJ, Robichaud N, Bishov SD, Wilson JM. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells. Cancer Res 1987;47:3360-5.
-
(1987)
Cancer Res
, vol.47
, pp. 3360-3365
-
-
Fram, R.J.1
Robichaud, N.2
Bishov, S.D.3
Wilson, J.M.4
-
10
-
-
0036765964
-
Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase II study
-
Bretti S, Manzin E, Loddo C, Berruti A, Bombaci S, Vellani G, et al. Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase II study. Anticancer Res 2002;22:3039-43.
-
(2002)
Anticancer Res
, vol.22
, pp. 3039-3043
-
-
Bretti, S.1
Manzin, E.2
Loddo, C.3
Berruti, A.4
Bombaci, S.5
Vellani, G.6
-
11
-
-
0033857218
-
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study
-
von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000;18:3068-77.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3068-3077
-
-
von der Maase, H.1
Hansen, S.W.2
Roberts, J.T.3
Dogliotti, L.4
Oliver, T.5
Moore, M.J.6
-
12
-
-
0037392970
-
Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder
-
Malik IA, Aziz Z, Zaidi SH, Sethuraman G. Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol 2003;26:174-7.
-
(2003)
Am J Clin Oncol
, vol.26
, pp. 174-177
-
-
Malik, I.A.1
Aziz, Z.2
Zaidi, S.H.3
Sethuraman, G.4
-
13
-
-
0242356582
-
Phase II study of gemcitabine plus cisplatin in biliary tract cancer
-
(abstract)
-
Thongprasert S, Napapan S, Charoentum C, Pojuchamarnwiputh S, Moonprakan S. Phase II study of gemcitabine plus cisplatin in biliary tract cancer. Proc Am Soc Clin Oncol 2003;22:1221(abstract).
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 1221
-
-
Thongprasert, S.1
Napapan, S.2
Charoentum, C.3
Pojuchamarnwiputh, S.4
Moonprakan, S.5
-
14
-
-
10844278711
-
A well tolerated and highly effective regimen for locally advanced and metastatic biliary tract cancers with gemcitabine and cisplatin
-
(abstract)
-
Baluch S. Lau J, Dhillon T, Wasan HS. A well tolerated and highly effective regimen for locally advanced and metastatic biliary tract cancers with gemcitabine and cisplatin. Proc Am Soc Clin Oncol 2003;22: 1473(abstract).
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 1473
-
-
Baluch, S.1
Lau, J.2
Dhillon, T.3
Wasan, H.S.4
-
15
-
-
0028860304
-
Liver, gallbladder, extrahepatic bile ducts and pancreas
-
Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts and pancreas. Cancer 1995;75(1 Suppl):171-90.
-
(1995)
Cancer
, vol.75
, Issue.1 SUPPL.
, pp. 171-190
-
-
Carriaga, M.T.1
Henson, D.E.2
-
16
-
-
1842631407
-
Chemotherapy in the elderly
-
Lichtman SM. Chemotherapy in the elderly. Semin Oncol 2004;31:160-74.
-
(2004)
Semin Oncol
, vol.31
, pp. 160-174
-
-
Lichtman, S.M.1
-
17
-
-
0034001776
-
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity
-
Adjei AA, Klein CE, Kastrissios H, Goldberg RM, Alberta SR, Pitot HC, et al. Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity. J Clin Oncol 2000;18:1116-23.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1116-1123
-
-
Adjei, A.A.1
Klein, C.E.2
Kastrissios, H.3
Goldberg, R.M.4
Alberta, S.R.5
Pitot, H.C.6
-
18
-
-
0032526183
-
Phase II trial of 5-fluorouracil, leucovorin and carboplatin in patients with unresectable biliary tree carcinoma
-
Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. Phase II trial of 5-fluorouracil, leucovorin and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998;82:2321-5.
-
(1998)
Cancer
, vol.82
, pp. 2321-2325
-
-
Sanz-Altamira, P.M.1
Ferrante, K.2
Jenkins, R.L.3
Lewis, W.D.4
Huberman, M.S.5
Stuart, K.E.6
|